End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.34 CNY | -3.07% | -3.13% | -0.58% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Sales 2024 * | 3.06B 423M | Sales 2025 * | 4.09B 564M | Capitalization | 42.62B 5.88B |
---|---|---|---|---|---|
Net income 2024 * | 722M 99.62M | Net income 2025 * | 952M 131M | EV / Sales 2024 * | 13.4 x |
Net cash position 2024 * | 1.57B 216M | Net cash position 2025 * | 5B 690M | EV / Sales 2025 * | 9.2 x |
P/E ratio 2024 * |
59.1
x | P/E ratio 2025 * |
46.4
x | Employees | 1,887 |
Yield 2024 * |
0.88% | Yield 2025 * |
0.43% | Free-Float | 22.71% |
1 day | -3.07% | ||
1 week | -3.13% | ||
Current month | -3.13% | ||
1 month | -13.64% | ||
3 months | +6.08% | ||
6 months | -4.29% | ||
Current year | -0.58% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Han
CEO | Chief Executive Officer | 50 | 15-12-31 |
Long Dai
DFI | Director of Finance/CFO | 32 | 23-04-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Pan
CHM | Chairman | 55 | - |
Huai Yu Wang
BRD | Director/Board Member | 61 | 15-12-31 |
Ji Yong Zhang
CHM | Chairman | - | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 30.34 | -3.07% | 12,315,980 |
24-06-06 | 31.3 | -0.89% | 6,376,033 |
24-06-05 | 31.58 | +0.54% | 6,096,640 |
24-06-04 | 31.41 | +2.98% | 9,120,585 |
24-06-03 | 30.5 | -2.62% | 12,413,370 |
End-of-day quote Shenzhen S.E., June 06, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.58% | 5.88B | |
+10.73% | 7.96B | |
+5.95% | 7.66B | |
-6.11% | 3.72B | |
-13.21% | 3.47B | |
-15.49% | 1.16B | |
-26.41% | 1.12B | |
+9.98% | 948M | |
-11.42% | 905M | |
-13.08% | 831M |
- Stock Market
- Equities
- 300765 Stock